Advanced search
Publication Cover
Infectious Diseases Volume 47, 2015 - Issue 10
Submit an article Journal homepage
246
Views
7
CrossRef citations to date
0
Altmetric
CASE REPORT

Even high-dose extended infusions may not yield desired concentrations of β-lactams: the value of therapeutic drug monitoring

Menino Osbert CottaFrom the Burns Trauma and Critical Care Research Centre, University of Queensland, Queensland, Australia;Royal Brisbane and Women's Hospital, Brisbane, Queensland, AustraliaCorrespondence[email protected]
,
Belinda GowenRoyal Brisbane and Women's Hospital, Brisbane, Queensland, Australia
,
Natasha TruloffRoyal Brisbane and Women's Hospital, Brisbane, Queensland, Australia
,
Evan BursleRoyal Brisbane and Women's Hospital, Brisbane, Queensland, Australia;Pathology Queensland, Brisbane, Queensland, Australia
,
Brett McWhinneyPathology Queensland, Brisbane, Queensland, Australia
,
Jacobus P.J. UngererPathology Queensland, Brisbane, Queensland, Australia
,
Jason A. RobertsFrom the Burns Trauma and Critical Care Research Centre, University of Queensland, Queensland, Australia;Royal Brisbane and Women's Hospital, Brisbane, Queensland, Australia
&
Jeffrey LipmanFrom the Burns Trauma and Critical Care Research Centre, University of Queensland, Queensland, Australia;Royal Brisbane and Women's Hospital, Brisbane, Queensland, Australia
 show all
Pages 739-742 | Received 12 Nov 2014, Accepted 13 Feb 2015, Published online: 10 Mar 2015

References

  • Jamal JA, Economou C, Lipman J, Roberts JA. Improving antibiotic dosing in special situations in the ICU: burns, renal replacement therapy and extracorporeal membrane oxygenation. Curr Opin Crit Care 2012;18:460–71.
  • Fitzwater J, Purdue G, Hunt J, O’Keefe G. The risk factors and time course of sepsis and organ dysfunction after burn trauma. J Trauma 2003;54:959–66.
  • Queensland Health. State of our Public Hospitals in Queensland. Brisbane; 2007.
  • Chim H, Tan B, Song C. Five-year review of infections in a burn intensive care unit: high incidence of Acinetobacter baumannii in a tropical climate. Burns 2007;33:1008–14.
  • Sinnollareddy M, Roberts M, Lipman J, Roberts J.β-lactam pharmacokinetics and pharmacodynamics in critically ill patients and strategies for dose optimization: a structured review. Clin Exp Pharmacol Physiol 2012;39:489–96.
  • Mouton J, Vinks AA. Continuous infusion of beta-lactams. Curr Opin Crit Care 2007;13:598–606.
  • Patel B, Paratz J, See N, Muller M, Rudd M, Paterson D, et al. Therapeutic drug monitoring of beta-lactam antibiotics in burns patients—a one-year prospective study. Ther Drug Monit 2012;34:160–4.
  • Turnidge J. The pharmacodynamics of beta-lactams. Clin Infect Dis 1998;27:10–22.
  • Manduru M, Mihm L, White R, Friedrich L, Flume P, Bosso J. In vitro pharmacodynamics of ceftazidime against Pseudomonas aeruginosa isolates from cystic fibrosis patients. Antimicrob Agents Chemother 1997;41:2053–6.
  • Tam V, McKinnon P, Akins R, Rybak M, Drusano G. Pharmacodynamics of cefepime in patients with Gram-negative infections. J Antimicrob Chemother 2002;50:425–8.
  • Tam VH, Schilling A, Neshat S, Poole K, Melnick D, Coyle E. Optimization of meropenem minimum concentration/MIC ratio to suppress in vitro resistance of Pseudomonas aeruginosa. Antimicrob Agents Chemother 2005;49:4920–7.
  • Li C, Du X, Kuti J, Nicolau D. Clinical pharmacodynamics of meropenem in patients with lower respiratory tract infections. Antimicrob Agents Chemother 2007;51:1725–30.
  • Craig W. Pharmacokinetic/pharmacodynamic parameters: rationale for antibacterial dosing of mice and men. Clin Infect Dis 1998;26:1–12
  • Gerber A, Vastola A, Brandel J, Craig WA. Selection of aminoglycoside-resistant variants of Pseudomonas aeruginosa in an in vivo model. J Infect Dis 1982;146:691–7.
  • Nasser S, Mabrouk A, Maher A. Colonization of burn wounds in Ain Shams University Burn Unit. Burns 2003; 29:229–33.
  • Pirnay J-P, De Vos D, Cochez C, Bilocq F, Pirson J, Struelens M, et al. Molecular epidemiology of Pseudomonas aeruginosa colonization in a burn unit: persistence of a multidrug-resistant clone and a silver sulfadiazine-resistant clone. J Clin Microbiol 2003;41:1192–202.
  • Roberts JA, Lipman J. Pharmacokinetic issues for antibiotics in the critically ill patient. Crit Care Med 2009;37:840–51.
  • Udy AA, Roberts JA, Shorr AF, Boots RJ, Lipman J. Augmented renal clearance in septic and traumatized patients with normal plasma creatinine concentrations: identifying at-risk patients. Crit Care 2013;17:R35.
  • Lorente L, Lorenzo L, Martín M, Jiménez A, Mora M. Meropenem by continuous versus intermittent infusion in ventilator-associated pneumonia due to gram-negative bacilli. Ann Pharmacother 2006;40:219–23.
  • Wong G, Brinkman A, Benefield RJ, Carlier M, De Waele JJ, El Helali N, et al. An international, multicentre survey of β-lactam antibiotic therapeutic drug monitoring practice in intensive care units. J Antimicrob Chemother 2014;69:1416–23.

Reprints and Corporate Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

To request a reprint or corporate permissions for this article, please click on the relevant link below:

Order Reprints Request Corporate Permissions

Academic Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

Obtain permissions instantly via Rightslink by clicking on the button below:

Request Academic Permissions

If you are unable to obtain permissions via Rightslink, please complete and submit this Permissions form. For more information, please visit our Permissions help page.

Related research

People also read lists articles that other readers of this article have read.

Recommended articles lists articles that we recommend and is powered by our AI driven recommendation engine.

Cited by lists all citing articles based on Crossref citations.
Articles with the Crossref icon will open in a new tab.